Concepedia

Dailan Danforth

DD

Statistics

Publications

1

Citations

11

H-Index

1

Active since

2021

Affiliations

Theradex Oncology (United States)(Current)

Dailan Danforth is an author at Theradex Oncology (United States) specializing in targeted cancer therapy, histone deacetylase targets, and targeted therapy.

Publications per year

2021–2021

1

Publications

1

Phase Ia dose escalation study of OBP-801, a cyclic depsipeptide class I histone deacetylase inhibitor, in patients with advanced solid tumors

Elisabeth I. Heath, Amy Weise, Ulka N. Vaishampayan et al. · Investigational New Drugs · 2021 · 11 citations

, , +9

1–1 of 1